Skip to main navigation
Close
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Breadcrumb
Association for Accessible Medicines
Resources
Resources
Share
Find up-to-date information on generics and biosimilars
Filter Resources
Issues
Biosimilar User Fee Act (BsUFA)
Biosimilars
Complex Generics
Drug Approval Process (GDUFA)
Drug Prices
Drug Shortages
Generic Drug Labeling
Generic Supply Chain
IP Issues
Low Income Subsidies (LIS in Part D)
Medicaid
Medicare
NAFTA
Patent Reform
Patient Stories
Pharmaceutical Waste Take Back
Preventing Drug Abuse
Quality
REMS/Sample Acquisition Remedies
State Initiatives
Tariffs
Trade
Transparency
User Fees
Resource Type
Blog
Amicus Brief
Press Release
Infographic
Video
Report
Fact Sheet
Presentation
Video
Jan 17, 2019
| Erica Klinger
Jonnie's Story – Savings from Generic Medicines
Blog
Jan 16, 2019
| Rachel Schwartz
Thanks to Her Generic Prescriptions, Jonnie is Oklahoma O.K.
Blog
Jan 15, 2019
| Erica Klinger
Take Our Generic Prescriptions Quiz!
Video
Dec 14, 2018
| Erica Klinger
Keon's Story – Savings from Generic Medicines
Video
Dec 14, 2018
| Erica Klinger
Better Your Business at Access! 2019
Press Release
Dec 13, 2018
| Rachel Schwartz
AAM Statement on FDA Withdrawal of Generic Drug Labeling Rule
Press Release
Dec 10, 2018
| Rachel Schwartz
Andrew O’Connor Joins AAM as Manager, State Government Affairs
Press Release
Nov 30, 2018
| Rachel Schwartz
AAM Statement on Signing of USMCA by President
Blog
Nov 28, 2018
| Jewel Smith
You’re Invited! AAM Strategic Priorities Planning for the New Year
Blog
Nov 28, 2018
| Chip Davis
BCBS: It’s time to CREATE more choices & lower drug prices
Blog
Nov 27, 2018
| David Gaugh
Preliminary Recommendations for Addressing Drug Shortages
Video
Nov 19, 2018
| Erica Klinger
AAM CEO Chip Davis: Midterm Elections Will Impact Your Business
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2024
GRx+Biosims 2023
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action